Clincosm LogoSign in Get a demo

Myelofibrosis

Showing 1 - 25 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Nov 9, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Aug 30, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Myelofibrosis Trial in Changchun (TQ05105 Tablets)

Completed
  • Myelofibrosis
  • TQ05105 Tablets
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Aug 1, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Health Promotion and Education
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 24, 2023

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Healthcare Resource Utilization in Adult Myelofibrosis Through

Recruiting
  • Myelofibrosis
    • La Plata, Buenos Aires, Argentina
    • +62 more
    Feb 1, 2023

    Myelofibrosis Trial in France (Clonal architecture determination)

    Not yet recruiting
    • Myelofibrosis
    • Clonal architecture determination
    • Angers, France
    • +6 more
    Jan 24, 2023

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Duarte, California
    • +4 more
    Jan 30, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

    Active, not recruiting
    • Myelofibrosis
    • Chronic Myelomonocytic Leukemia
    • Duarte, California
    • +9 more
    Jan 24, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

    Recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    Jan 18, 2023

    Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +36 more
    Jan 13, 2023

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +13 more
    Jan 10, 2023

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +13 more
    • CMVpp65-A*0201 peptide vaccine
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023